Psychiatry & Neurology, Sleep Medicine · Minneapolis, MN
NPI
1255304770
Since 2006
Specialty
Psychiatry & Neurology, Sleep Medicine
Code 2084S0012X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
701 Park Ave
Minneapolis, MN, 55415
Phone (612) 873-6963
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
181 services
Medicare patients, 2024
109
Average age 61
Drug cost, 2024
$91K
919 prescriptions
Company payments, 2025
$968
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ranji Varghese was code 99214 (office e&m - established), 66 times for 57 patients. In total Ranji Varghese billed 181 services in 13 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 66 | 57 | $70.45 | $4,649 |
| 99214 Office E&M - Established | Office | 48 | 23 | $91.30 | $4,382 |
| 95811 Sleep Study | Facility | 15 | 15 | $87.24 | $1,309 |
| 95810 Sleep Study | Facility | 14 | 14 | $87.65 | $1,227 |
By year: 2022 $22K for 295 services; 2023 $12K for 163 services; 2024 $15K for 181 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ranji Varghese prescribed most often to Medicare patients was Methylphenidate Hcl, with 132 prescriptions and refills. In total Ranji Varghese wrote 919 Medicare prescriptions that cost $91K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methylphenidate Hcl Generic | 132 | 140 | 39 | $5,981 |
| Zolpidem Tartrate Generic | 65 | 91 | 31 | $318 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 65 | 73 | 17 | $3,672 |
| Clonazepam Generic | 53 | 73 | 12 | $330 |
| Gabapentin Generic | 47 | 81 | 12 | $727 |
| Trazodone Hcl Generic | 43 | 84 | 14 | $391 |
| Lorazepam Generic | 41 | 59 | 11 | $843 |
| Methylphenidate Er Methylphenidate Hcl | 36 | 42 | 15 | $3,472 |
| Paroxetine Hcl Generic | 34 | 47 | Under 11 | $264 |
| Alprazolam Generic | 32 | 34 | Under 11 | $231 |
| Temazepam Generic | 25 | 29 | Under 11 | $264 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 25 | 29 | Under 11 | $2,050 |
| Methadone Hcl Generic | 22 | 30 | Under 11 | $490 |
| Bupropion Xl Bupropion Hcl | 22 | 40 | Under 11 | $469 |
| Modafinil Generic | 18 | 26 | Under 11 | $1,330 |
Brand drugs: 42 claims; generic drugs: 877 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ranji Varghese $968 ($968 in general payments such as food, travel and fees) from 1 company. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $968.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $968 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.